These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33725462)

  • 1. Highlighting the use of micro and nanoparticles based-drug delivery systems for the treatment of
    de Souza MPC; de Camargo BAF; Spósito L; Fortunato GC; Carvalho GC; Marena GD; Meneguin AB; Bauab TM; Chorilli M
    Crit Rev Microbiol; 2021 Aug; 47(4):435-460. PubMed ID: 33725462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastroretentive drug delivery systems for the treatment of Helicobacter pylori.
    Zhao S; Lv Y; Zhang JB; Wang B; Lv GJ; Ma XJ
    World J Gastroenterol; 2014 Jul; 20(28):9321-9. PubMed ID: 25071326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of nanotechnology-based treatment approaches against Helicobacter Pylori.
    Safarov T; Kiran B; Bagirova M; Allahverdiyev AM; Abamor ES
    Expert Rev Anti Infect Ther; 2019 Oct; 17(10):829-840. PubMed ID: 31591930
    [No Abstract]   [Full Text] [Related]  

  • 4. New Silver(I) Coordination Compound Loaded into Polymeric Nanoparticles as a Strategy to Improve
    Almeida Furquim de Camargo B; Soares Silva DE; Noronha da Silva A; Campos DL; Machado Ribeiro TR; Mieli MJ; Borges Teixeira Zanatta M; Bento da Silva P; Pavan FR; Gallina Moreira C; Resende FA; Menegário AA; Chorilli M; Vieira de Godoy Netto A; Bauab TM
    Mol Pharm; 2020 Jul; 17(7):2287-2298. PubMed ID: 32515970
    [No Abstract]   [Full Text] [Related]  

  • 5. Gastroretentive dosage forms: overview and special case of Helicobacter pylori.
    Bardonnet PL; Faivre V; Pugh WJ; Piffaretti JC; Falson F
    J Control Release; 2006 Mar; 111(1-2):1-18. PubMed ID: 16403588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori: an overview on antimicrobials and drug delivery systems for its eradication.
    El-Zahaby SA; Kassem AA; El-Kamel AH
    Curr Drug Deliv; 2014; 11(3):306-12. PubMed ID: 24678600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residence Time-Extended Nanoparticles by Magnetic Field Improve the Eradication Efficiency of
    Yang SJ; Huang CH; Yang JC; Wang CH; Shieh MJ
    ACS Appl Mater Interfaces; 2020 Dec; 12(49):54316-54327. PubMed ID: 33236884
    [No Abstract]   [Full Text] [Related]  

  • 8. Floating-bioadhesive gastroretentive Caesalpinia pulcherrima-based beads of amoxicillin trihydrate for Helicobacter pylori eradication.
    Thombre NA; Gide PS
    Drug Deliv; 2016; 23(2):405-19. PubMed ID: 24870198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Helicobacterpylori effectiveness and targeted delivery performance of amoxicillin-UCCs-2/TPP nanoparticles based on ureido-modified chitosan derivative.
    Jing ZW; Luo M; Jia YY; Li C; Zhou SY; Mei QB; Zhang BL
    Int J Biol Macromol; 2018 Aug; 115():367-374. PubMed ID: 29660462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polysaccharides as Bacterial Antiadhesive Agents and "Smart" Constituents for Improved Drug Delivery Systems Against Helicobacter pylori Infection.
    Menchicchi B; Hensel A; Goycoolea FM
    Curr Pharm Des; 2015; 21(33):4888-906. PubMed ID: 26290206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eradication of Helicobacter pylori: Past, present and future.
    Lopes D; Nunes C; Martins MC; Sarmento B; Reis S
    J Control Release; 2014 Sep; 189():169-86. PubMed ID: 24969353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential utility of nano-based treatment approaches to address the risk of
    Khan S; Sharaf M; Ahmed I; Khan TU; Shabana S; Arif M; Kazmi SSUH; Liu C
    Expert Rev Anti Infect Ther; 2022 Mar; 20(3):407-424. PubMed ID: 34658307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori: past, current and future treatment strategies with gastroretentive drug delivery systems.
    Verma A; Dubey J; Hegde RR; Rastogi V; Pandit JK
    J Drug Target; 2016 Dec; 24(10):897-915. PubMed ID: 27027827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles incorporated in pH-sensitive hydrogels as amoxicillin delivery for eradication of Helicobacter pylori.
    Chang CH; Lin YH; Yeh CL; Chen YC; Chiou SF; Hsu YM; Chen YS; Wang CC
    Biomacromolecules; 2010 Jan; 11(1):133-42. PubMed ID: 19924885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characterization of nanolipobeads-based dual drug delivery system for H. pylori targeting.
    Jain AK; Jain SK
    J Drug Target; 2013 Jul; 21(6):593-603. PubMed ID: 23597027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Floating in situ gelling system for stomach site-specific delivery of clarithromycin to eradicate H. pylori.
    Rajinikanth PS; Mishra B
    J Control Release; 2008 Jan; 125(1):33-41. PubMed ID: 18006101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering bioinspired bacteria-adhesive clay nanoparticles with a membrane-disruptive property for the treatment of Helicobacter pylori infection.
    Ping Y; Hu X; Yao Q; Hu Q; Amini S; Miserez A; Tang G
    Nanoscale; 2016 Sep; 8(36):16486-98. PubMed ID: 27605059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection.
    Gonçalves IC; Henriques PC; Seabra CL; Martins MC
    Expert Rev Anti Infect Ther; 2014 Aug; 12(8):981-92. PubMed ID: 24981812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastroretentive microparticles for drug delivery applications.
    Adebisi A; Conway BR
    J Microencapsul; 2011; 28(8):689-708. PubMed ID: 21726124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of drug delivery to improve antibiotic targeting to the stomach.
    Adebisi AO; Conway BR
    Ther Deliv; 2015; 6(6):741-62. PubMed ID: 26149788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.